{"entity":{"type":"insider","cik":"0001520533","url":"/insider/0001520533","json_url":"/insider/0001520533.json","name":"SCHLOSSBERG MARK A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2013-03-14","last":"2022-03-15","span_basis":"filed_date"},"name_variants":[{"name":"SCHLOSSBERG MARK A","source":"filing","n_filings":7,"first_seen":"2013-03-14","last_seen":"2022-03-15"}],"transactions":[{"id":6695051,"accession":"0001061983-22-000077","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-22-000077","line_url":"/filing/0001061983-22-000077#line-4","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001520533","owner_name":"SCHLOSSBERG MARK A","owner_display_name":"SCHLOSSBERG MARK A","owner_url":"/insider/0001520533","role":"Officer (SVP - Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP - Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP - Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25196.0,"shares_display":"25,196","price_per_share":33.9627,"price_display":"33.96","price_state":"stated","total_value":855724.1892,"total_display":"855,724.19","total_whole":"855,724","shares_owned_after":103408.0,"shares_owned_after_display":"103,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-15","scope":"insider"},{"id":5528692,"accession":"0001061983-21-000241","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-21-000241","line_url":"/filing/0001061983-21-000241#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001520533","owner_name":"SCHLOSSBERG MARK A","owner_display_name":"SCHLOSSBERG MARK A","owner_url":"/insider/0001520533","role":"Officer (SVP - Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP - Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP - Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19979.0,"shares_display":"19,979","price_per_share":35.736,"price_display":"35.74","price_state":"stated","total_value":713969.544,"total_display":"713,969.54","total_whole":"713,970","shares_owned_after":50850.0,"shares_owned_after_display":"50,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-19","filed_date":"2021-10-20","scope":"insider"},{"id":2637683,"accession":"0001061983-20-000143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-20-000143","line_url":"/filing/0001061983-20-000143#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001520533","owner_name":"SCHLOSSBERG MARK A","owner_display_name":"SCHLOSSBERG MARK A","owner_url":"/insider/0001520533","role":"Officer (SVP - Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP - Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP - Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-21","filed_date":"2020-08-21","scope":"insider"},{"id":2291562,"accession":"0001061983-20-000135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-20-000135","line_url":"/filing/0001061983-20-000135#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001520533","owner_name":"SCHLOSSBERG MARK A","owner_display_name":"SCHLOSSBERG MARK A","owner_url":"/insider/0001520533","role":"Officer (SVP - Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP - Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP - Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":23.0728,"price_display":"23.07","price_state":"stated","total_value":230728.0,"total_display":"230,728.00","total_whole":"230,728","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-29","filed_date":"2020-07-30","scope":"insider"},{"id":8804854,"accession":"0001437749-15-017258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-15-017258","line_url":"/filing/0001437749-15-017258#line-1","is_derivative":false,"issuer_cik":"0001003642","issuer_name":"IMPAX LABORATORIES INC","issuer_ticker":"IPXL","issuer_name_source":null,"issuer_url":"/issuer/0001003642","owner_cik":"0001520533","owner_name":"SCHLOSSBERG MARK A","owner_display_name":"SCHLOSSBERG MARK A","owner_url":"/insider/0001520533","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7457.0,"shares_display":"7,457","price_per_share":43.3,"price_display":"43.30","price_state":"stated","total_value":322888.1,"total_display":"322,888.10","total_whole":"322,888","shares_owned_after":73588.0,"shares_owned_after_display":"73,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-11","filed_date":"2015-09-14","scope":"insider"},{"id":8936605,"accession":"0001437749-15-016549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-15-016549","line_url":"/filing/0001437749-15-016549#line-1","is_derivative":false,"issuer_cik":"0001003642","issuer_name":"IMPAX LABORATORIES INC","issuer_ticker":"IPXL","issuer_name_source":null,"issuer_url":"/issuer/0001003642","owner_cik":"0001520533","owner_name":"SCHLOSSBERG MARK A","owner_display_name":"SCHLOSSBERG MARK A","owner_url":"/insider/0001520533","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4649.0,"shares_display":"4,649","price_per_share":43.41,"price_display":"43.41","price_state":"stated","total_value":201813.09,"total_display":"201,813.09","total_whole":"201,813","shares_owned_after":81045.0,"shares_owned_after_display":"81,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-27","filed_date":"2015-08-27","scope":"insider"},{"id":5377596,"accession":"0001437749-13-002917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-13-002917","line_url":"/filing/0001437749-13-002917#line-1","is_derivative":false,"issuer_cik":"0001003642","issuer_name":"IMPAX LABORATORIES INC","issuer_ticker":"IPXL","issuer_name_source":null,"issuer_url":"/issuer/0001003642","owner_cik":"0001520533","owner_name":"SCHLOSSBERG MARK A","owner_display_name":"SCHLOSSBERG MARK A","owner_url":"/insider/0001520533","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":16.728,"price_display":"16.73","price_state":"stated","total_value":16728.0,"total_display":"16,728.00","total_whole":"16,728","shares_owned_after":36916.0,"shares_owned_after_display":"36,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-12","filed_date":"2013-03-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001061983","name":"CYTOKINETICS INC","url":"/issuer/0001061983","role":"Officer (SVP - Legal & General Counsel)","n_filings":4,"first_seen":"2020-07-30","last_seen":"2022-03-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001003642","name":"IMPAX LABORATORIES INC","url":"/issuer/0001003642","role":"Officer (SVP and General Counsel)","n_filings":3,"first_seen":"2013-03-14","last_seen":"2015-09-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001520533","retrieved_at":"2026-08-27T07:18:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}